Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,319
datasets available to search
ShareScore release 0.9.0
Dataset results
1,319 results for “crohns disease”
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00409682. IPD Sharing: Not stated. Countries: 8. Publications: 3.
The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease
ClinicalTrials.gov study NCT00715117. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
ClinicalTrials.gov study NCT01369342. IPD Sharing: Not stated. Countries: 22. Publications: 12.
Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator
ClinicalTrials.gov study NCT00094458. IPD Sharing: Not stated. Countries: 15. Publications: 7.
Study for the Treatment of Crohn's Disease With Adacolumn
ClinicalTrials.gov study NCT00162942. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
ClinicalTrials.gov study NCT00552058. IPD Sharing: Not stated. Countries: 20. Publications: 3.
Oral N-acetylglucosamine in Crohn's Disease
ClinicalTrials.gov study NCT07225998. IPD Sharing: YES. Countries: 1. Publications: 2.
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
ClinicalTrials.gov study NCT00195715. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
ClinicalTrials.gov study NCT00409617. IPD Sharing: Not stated. Countries: 17. Publications: 1.
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
ClinicalTrials.gov study NCT01470599. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03440372. IPD Sharing: Not stated. Countries: 35. Publications: 1.
A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease
ClinicalTrials.gov study NCT00445939. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
ClinicalTrials.gov study NCT02208310. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT00619489. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
ClinicalTrials.gov study NCT05668013. IPD Sharing: YES. Countries: 16. Publications: 0.
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT01224171. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Induction Optimization With Stelara for Crohn's Disease
ClinicalTrials.gov study NCT04629196. IPD Sharing: YES. Countries: 1. Publications: 1.
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
ClinicalTrials.gov study NCT05332639. IPD Sharing: YES. Countries: 1. Publications: 1.
Special Investigation in Patients With Crohn's Disease (All Patients Investigation)
ClinicalTrials.gov study NCT01298648. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
ClinicalTrials.gov study NCT00844285. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.